When DS Cormac Reilly’s girlfriend Emma stumbles across the victim of a hit and run early one morning, he is first on the scene of a murder that would otherwise never have been assigned to him. The dead girl is carrying an ID, that of Carline Darcy, heir apparent to Darcy Therapeutics, Ireland’s most successful pharmaceutical company. Darcy Therapeutics has a finger in every pie, from sponsoring university research facilities to funding political parties to philanthropy – it has funded Emma’s own ground-breaking research. The investigation into Carline’s death promises to be high profile and high pressure. As Cormac investigates, evidence mounts that the death is linked to a Darcy laboratory and, increasingly, to Emma herself. Cormac is sure she couldn’t be involved, but how well does he really know the woman he loves? The second book in the Cormac Reilly series is a gripping and twisty thriller about loyalty, ambition, and the dangerous intersection of science and big business.
The Scholar
Year
2019
Pages
377
Description
When DS Cormac Reilly’s girlfriend Emma stumbles across the victim of a hit and run early one morning, he is first on the scene of a murder that would otherwise never have been assigned to him. The dead girl is carrying an ID, that of Carline Darcy, heir apparent to Darcy Therapeutics, Ireland’s most successful pharmaceutical company. Darcy Therapeutics has a finger in every pie, from sponsoring university research facilities to funding political parties to philanthropy – it has funded Emma’s own ground-breaking research. The investigation into Carline’s death promises to be high profile and high pressure. As Cormac investigates, evidence mounts that the death is linked to a Darcy laboratory and, increasingly, to Emma herself. Cormac is sure she couldn’t be involved, but how well does he really know the woman he loves? The second book in the Cormac Reilly series is a gripping and twisty thriller about loyalty, ambition, and the dangerous intersection of science and big business.
What to read after The Scholar.
Tell us what you’re craving.
